Soleno earnings release
WebMay 6, 2024 · Soleno Therapeutics, Inc. SLNO will report first-quarter 2024 earnings results. The company’s performance over the trailing four quarters has been encouraging with its … WebNov 13, 2024 · Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results Author PressReach Posted on November 13, 2024 Categories …
Soleno earnings release
Did you know?
WebJul 27, 2024 · Soleno Therapeutics, Inc. SLNO will provide updates on its pipeline candidates when it releases second-quarter 2024 results. The company has a mixed track record, … WebDec 31, 2024 · What were Soleno Therapeutics’s (NASDAQ:SLNO) revenues? A. The Actual Revenue was $0K, which missed the estimate of $2.6M. Browse earnings estimates, EPS, …
WebMar 21, 2024 · Soleno Therapeutics Inc (SLNO) SEC Filing 8-K Material Event for the period ending Tuesday, March 21, 2024 WebApr 2, 2024 · Soleno Therapeutics (SLNO) will release its next earnings report on Apr 3, 2024. In the last quarter Soleno Therapeutics reported -$0.91 EPS in relation to -$0.76 …
WebJan 26, 2024 · Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), is currently being evaluated in a Phase 3 clinical development program. WebApr 19, 2024 · DUBLIN, Apr. 19, 2024 /PRNewswire/ --. Research and Markets has announced the addition of the "Global HDPE Pipes Market Size, Market Share, Application Analysis, …
WebView the latest Soleno Therapeutics Inc. (SLNO) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebJan 26, 2024 · Diazoxide Choline Controlled-Release (DCCR) Learn More. ... March 28, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical … macaulay culkin mental health issuesWebMar 21, 2024 · About DCCR (Diazoxide Choline) Extended-Release TabletsDCCR is a novel, proprietary extended-release dosage form containing the crystalline salt of diazoxide and … kitchenaid ice maker parts manualWebSOLENO THERAPEUTICS INC : Press releases relating to SOLENO THERAPEUTICS INC Investor relations Nasdaq: Nasdaq macaulay culkin ted danson movieWebGet the latest Soleno Therapeutics earnings report, revenues and EPS as well as upcoming SLNO earnings dates. ... Release Date Period End EPS / Forecast Revenue / Forecast; Aug … macaulay culkin successionWebApr 13, 2024 · Electrameccanica Vehicles has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 11th, 2024 based off … macaulay culkin red shoe menmacaulay culkin talks about red shoesWebJan 13, 2024 · Earnings Estimate Revisions for Soleno Therapeutics, Inc. This company is expected to earn -$0.48 per share for the fiscal year ending December 2024, which represents a year-over-year change of 92%. macaulay culkin s brother